Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.45
+0.13 (2.06%)
At close: Jan 22, 2026, 4:00 PM EST
6.37
-0.08 (-1.24%)
After-hours: Jan 22, 2026, 6:23 PM EST
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $419.4 million as of January 22, 2026. Its market cap has increased by 148.97% in one year.
Market Cap
419.40M
Enterprise Value
273.88M
1-Year Change
148.97%
Ranking
Category
Stock Price
$6.45
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $419.40M, an increase of 150.65%. That is a compound annual growth rate of 23.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 410.95M | 20.61% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 355.61M |
| Aardvark Therapeutics | 337.70M |
| AC Immune | 336.41M |
| Foghorn Therapeutics | 329.81M |
| Puma Biotechnology | 329.81M |
| Candel Therapeutics | 329.39M |
| XOMA Royalty | 327.16M |
| Neumora Therapeutics | 321.18M |